Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial
(2023)
Journal Article
Santer, M., Lawrence, M., Renz, S., Eminton, Z., Stuart, B., Sach, T. H., …Layton, A. M. (2023). Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ, 381, Article e074349. https://doi.org/10.1136/bmj-2022-074349
Objective: To assess the effectiveness of oral spironolactone for acne vulgaris in adult women.
Design: Pragmatic, multicentre, phase 3, double blind, randomised controlled trial.
Setting: Primary and secondary healthcare, and advertising in th...
Read More about Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial.